Johanna Lempainen
Clinical lecturer
johanna.lempainen@utu.fi Department of Pediatrics, Institute of Clinical Medicine, University of Turku Unit for Rare Diseases, Turku University Hospital |
Asiantuntijuusalueet
Lastentaudit; Autoimmuniteetti, Infektiot ja immuniteetti, Tyypin 1 diabetes
Lastentaudit; Autoimmuniteetti, Infektiot ja immuniteetti, Tyypin 1 diabetes
Biografia
Docent Johanna Lempainen
graduated from medical school in 2004 (University of Turku) and defended her
PhD theses on pathogenesis of type 1 diabetes in 2009. She received specialist
licence in paediatrics in 2015 and was appointed as a docent of experimental
paediatrics in 2018 (University of Turku). She is currently working as clinical
lecturer at the department of pediatrics at University of Turku and as
specialist at the Unit for Rare Diseases, Turku University Hospital. She
participates in neonatal screening for severe immunodeficiencies and in
laboratory diagnostics of immunodeficiencies. Training for subspecialty in
pediatric infections and immunodeficiencies is ongoing.
Docent Johanna Lempainen
graduated from medical school in 2004 (University of Turku) and defended her
PhD theses on pathogenesis of type 1 diabetes in 2009. She received specialist
licence in paediatrics in 2015 and was appointed as a docent of experimental
paediatrics in 2018 (University of Turku). She is currently working as clinical
lecturer at the department of pediatrics at University of Turku and as
specialist at the Unit for Rare Diseases, Turku University Hospital. She
participates in neonatal screening for severe immunodeficiencies and in
laboratory diagnostics of immunodeficiencies. Training for subspecialty in
pediatric infections and immunodeficiencies is ongoing.
Tutkimus
Docent Lempainen’s
thesis in 2009 focused on the pathogenesis of type 1 diabetes. Since then her
research work has further focused on the heterogeneity of type 1 diabetes
pathogenesis. In 2011 she worked as visiting researcher in the
BabyDiab-diabetes study group in Munich,
Germany. Her current research interests comprise the etiology of beta-cell
autoimmunity in respect of immunological, genetic and epigenetic factors and
disturbances in early microbial contacts and are a part of the prospective
Diabetes Prediction and Prevention (DIPP) study. In addition, she participates
in research projects aiming at early detection of bacterial and viral
infections in infants and children in order to avoid unnecessary antibiotic
exposure. Since January 2020 docent Lempainen is the principal investigator of the Immunogenetics laboratory and PI and member of steering committee in the DIPP study at the University of Turku.
Docent Lempainen’s
thesis in 2009 focused on the pathogenesis of type 1 diabetes. Since then her
research work has further focused on the heterogeneity of type 1 diabetes
pathogenesis. In 2011 she worked as visiting researcher in the
BabyDiab-diabetes study group in Munich,
Germany. Her current research interests comprise the etiology of beta-cell
autoimmunity in respect of immunological, genetic and epigenetic factors and
disturbances in early microbial contacts and are a part of the prospective
Diabetes Prediction and Prevention (DIPP) study. In addition, she participates
in research projects aiming at early detection of bacterial and viral
infections in infants and children in order to avoid unnecessary antibiotic
exposure. Since January 2020 docent Lempainen is the principal investigator of the Immunogenetics laboratory and PI and member of steering committee in the DIPP study at the University of Turku.
Opetus
Docent Lempainen works
as clinical lecturer in pediatrics (part-time) since January 2017.
Docent Lempainen works
as clinical lecturer in pediatrics (part-time) since January 2017.
Julkaisut 
5/8
- Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients (2022)
- Frontiers in immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study2022
- Infectious Diseases
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute InfectionA Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies (2022)
- Microbiology spectrumJournal of Infectious Diseases
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Non-HLA Gene Polymorphisms in the Pathogenesis of Type 1 Diabetes: Phase and Endotype Specific EffectsVaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA VaccinationAssociations Between IFI44L Gene Variants and Rates of Respiratory Tract Infections During Early Childhood (2022)
- Frontiers in immunologyMicrobiology spectrum
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 InfectionViral infection-related gene upregulation in monocytes in children with signs of β-cell autoimmunity (2022)
- Open Forum Infectious DiseasesPediatric Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2022)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2022)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2021)
- Microbiology spectrum
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - (2021)
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants (2021)
- Nature Communications
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Turun yliopiston Tutkimustietojärjestelmän portaali